Avalo Therapeutics Inc (AVTX)
9.64
-0.75
(-7.22%)
USD |
NASDAQ |
May 16, 16:00
9.92
+0.28
(+2.90%)
After-Hours: 20:00
Avalo Therapeutics 1 Year Total Returns (Daily): -98.54% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -98.54% |
May 15, 2024 | -98.43% |
May 14, 2024 | -98.20% |
May 13, 2024 | -98.17% |
May 10, 2024 | -98.17% |
May 09, 2024 | -98.15% |
May 08, 2024 | -98.15% |
May 07, 2024 | -97.88% |
May 06, 2024 | -97.83% |
May 03, 2024 | -97.99% |
May 02, 2024 | -97.93% |
May 01, 2024 | -97.84% |
April 30, 2024 | -97.55% |
April 29, 2024 | -97.58% |
April 26, 2024 | -97.80% |
April 25, 2024 | -97.90% |
April 24, 2024 | -98.09% |
April 23, 2024 | -98.14% |
April 22, 2024 | -98.25% |
April 19, 2024 | -98.35% |
April 18, 2024 | -98.23% |
April 17, 2024 | -98.11% |
April 16, 2024 | -97.45% |
April 15, 2024 | -97.56% |
April 12, 2024 | -97.74% |
Date | Value |
---|---|
April 11, 2024 | -97.88% |
April 10, 2024 | -97.36% |
April 09, 2024 | -96.68% |
April 08, 2024 | -96.75% |
April 05, 2024 | -96.29% |
April 04, 2024 | -96.27% |
April 03, 2024 | -96.22% |
April 02, 2024 | -96.39% |
April 01, 2024 | -95.74% |
March 28, 2024 | -94.79% |
March 27, 2024 | -98.86% |
March 26, 2024 | -98.94% |
March 25, 2024 | -98.89% |
March 22, 2024 | -98.99% |
March 21, 2024 | -99.12% |
March 20, 2024 | -99.14% |
March 19, 2024 | -99.18% |
March 18, 2024 | -99.16% |
March 15, 2024 | -99.27% |
March 14, 2024 | -99.17% |
March 13, 2024 | -99.04% |
March 12, 2024 | -99.08% |
March 11, 2024 | -99.05% |
March 08, 2024 | -99.01% |
March 07, 2024 | -99.12% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.66%
Minimum
Jan 17 2024
93.53%
Maximum
Mar 16 2021
-45.73%
Average
-49.08%
Median
Apr 13 2020
1 Year Total Returns (Daily) Benchmarks
Imunon Inc | 11.11% |
iBio Inc | -90.27% |
Kodiak Sciences Inc | -35.74% |
Petros Pharmaceuticals Inc | -87.37% |
Ocugen Inc | 185.6% |